Efficacy of a mamma fieldblock in oncological breast surgery in reducing postoperative nausea and pain.

Efficacy of a mamma fieldblock in oncological breast surgery in reducing postoperative nausea and pain. - Efficacy of a mamma fieldblock in oncological breast surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30861

Enrollment

Registered

2007-08-15

Start date

2007-04-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain and nausea

Interventions

Mamma fieldblock.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Female patients for lumpectomy or ablatio mammae with of without axillary lymphnode dissection.

Exclusion criteria

Exclusion criteria: Allergy to local anesthetics. Chronic use pain medication.

Design outcomes

Primary

Measure	Time frame
Postoperative opioidconsumption. Postoperative pain, nausea and vomiting are scored using a numeric rating scale.	—

Secondary

Measure	Time frame
No secundary study parameters/outcome of the study defined	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)